Colliers Securities analyst Kyle Bauser reiterated a Buy rating on Ufp Technologies (UFPT – Research Report) today and set a price target of $86.00. The company’s shares closed last Thursday at $68.72.
According to TipRanks.com, Bauser is a 3-star analyst with an average return of 4.6% and a 43.7% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Chembio Diagnostics, Semler Scientific, and Motus Gi Holdings.
Currently, the analyst consensus on Ufp Technologies is a Moderate Buy with an average price target of $86.00.
Ufp Technologies’ market cap is currently $517.6M and has a P/E ratio of 30.93.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
UFP Technologies, Inc. operates as a designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. It produces products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. The firm’s single-use and single-patient devices and components are used in medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.
Read More on UFPT:
- Is Visa Stock’s Recovery Rally Worth Getting Behind?
- Is CytomX Stock a Buy Following Disappointing Cancer Therapy Results? Analyst Weighs In
- Foot Locker Highlights New Risk Factors After Acquisitions
- Qudian (QD) Gets a Hold Rating from Needham
- Siebert Williams Shank & Co Initiates a Buy Rating on Chesapeake Energy (CHK)